1. Mechanisms of Cardiac Arrhythmias
2. Class I Antiarrhythmic Drugs: Na+ Channel Blockers
3. Class III Antiarrhythmic Drugs
4. Beta-blockers as Antiarrhythmic Agents
5. Modulation of Calcium Handling: Calcium-Channel Modulators
6. Other Antiarrhythmic Drugs
7. Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy
8. Clinical Significance and Management of Arrhythmias
This volume reviews current and potential future therapies for arrhythmias. It is a highly practical guide for the use of pharmaceuticals in the management of the discipline, and has been written in a simple quick-access format.
Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.
• Presents highly practical information, written in a quick-access, no-nonsense format
• Emphasis is on a just-the-facts clinical approach, heavy on tabular material, light on dense prose
• Involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series
• A Martinez Rubio, is Chief of Cardiology in the Univ. Hospital of Sabadell and professor of Medicine at the Univ. Autònoma of Barcelona, Spain
• J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain
• G. Andrei Dan is Prof of Medicine at the Carol Davila University of Medicine, chief of the Internal Medicine Clinic and of Cardiology Department, Colentina University Hospital, Bucharest, Romania, immediate past President of ISCP